November 20, 2025 Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth read more
November 17, 2025 Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring read more
CTAD 2024 Quanterix Fireside Chat with Henrik Zetterburg: Advances in Blood-Based Biomarkers for Alzheimer’s Disease read more
October 9, 2025 Built for Translation: Why Simoa Stands Alone in Clinical-Grade Biomarker Measurement read more